Literature DB >> 29693863

DYKE-DAVIDOFF-MASSON SYNDROME - TYPICAL IMAGING FEATURES.

Mladen Bjelan, Dusko Kozic, Vesna Njagulj, Aleksandar Ragaji, Katarina Koprivsek, Milos Lucic.   

Abstract

INTRODUCTION: Dyke-Davidoff-Masson syndrome is an uncommon neurological disorder clinically presented with seizures, various degrees of mental retardation, motor weakness and sometimes body asymmetry. Typical neuroimaging features include cerebral hemiatrophy with ipsilateral hyper pneumatization of paranasal sinuses. The purpose of this report was to present a rare cause of seizures revealed by Magnetic resonance imaging. CASE REPORT: We report a case of a 17-year-old boy admitted to hospital due to a severe headache. He had been treated because of partial epileptic seizures for six years. Neuropsychological examination revealed mild mental retardation, mild speech and reading difficulties and discrete right-sided hemiparesis. Typical magnetic resonance imaging features confirmed clinical suspicion of Dyke-Davidoff-Masson syndrome. revealing left frontal lobe atrophy, with consecutive widening of the left lateral ventricle frontal horn, thickening of the nearby frontal squama and hypertrophy of left frontal sinus.
CONCLUSION: Magnetic resonance imaging is the key imaging modality that confirms clinical suspicion of Dyke-Davidoff-Masson syndrome based on a proper physical and neurological examination.

Entities:  

Mesh:

Year:  2016        PMID: 29693863     DOI: 10.2298/mpns1612373b

Source DB:  PubMed          Journal:  Med Pregl        ISSN: 0025-8105


  2 in total

1.  Case Report and Literature Review: COVID-19 and status epilepticus in Dyke-Davidoff-Masson syndrome.

Authors:  Lourdes de Fátima Ibañez Valdés; Jerry Geroge; Sibi Joseph; Mohamed Alshmandi; Wendy Makaleni; Humberto Foyaca Sibat
Journal:  F1000Res       Date:  2021-01-08

Review 2.  A potential cause of adolescent onset Dyke-Davidoff-Masson syndrome: A case report.

Authors:  Yiyang Li; Tao Zhang; Bo Li; Jing Li; Li Wang; Zhibin Jiang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.